Conference Proceedings

Interim analysis of ZUMA-12: a phase 2 study of axicabtagene ciloleucel as first-line therapy in patients with high-risk large B-cell lymphoma

Sattva S Neelapu, Michael Dickinson, Javier Munoz, Matthew L Ulrickson, Olalekan O Oluwole, Alex F Herrera, Catherine Thieblemont, Chaitra S Ujjani, Yi Lin, Peter A Riedell, Natasha Kekre, Sven De Vos, Yin Yang, Francesca Milletti, Lovely Goyal, Jun Kawashima, Julio C Chavez

BRITISH JOURNAL OF HAEMATOLOGY | WILEY | Published : 2021